Birth Defects Associated With Antidepressants
Since September 2005, information has been emerging that certain antidepressants may cause birth defects, including cardiac (heart), pulmonary (lung), neural-tube defects (brain and spinal cord), craniosynostosis (skull defect), infant omphalocele (abdominal wall defects), club foot (one or both feet turn downward and inward), and anal atresia (complete or partial closure of the anus), among others. We are currently investigating whether or not the following antidepressants also cause such birth defects:
Our legal birth defects team consists of 10 attorneys from two prestigious law firms that have more experience handling antidepressant birth defect cases than any other firm in the country. Through our litigation and consultation with medical experts, we are establishing the link between antidepressants and the following congenital defects:
PPHN: Persistent pulmonary hypertension (PPHN) is a serious and life-threatening lung condition that occurs soon after birth of the newborn. Babies with PPHN have high pressure in their lung blood vessels and are not able to get enough oxygen into their bloodstream. About 1 to 2 babies per 1000 babies born in the U.S. develop PPHN shortly after birth, and often they need intensive medical care.
On July 19, 2006, the FDA issued a Public Health Advisory for SSRIs, including Celexa (citalopram), Fluvoxamine, Lexapro (escitalopram), Prozac (fluoxetine), Symbyax (olanzapine and fluoxetine) and Zoloft (sertraline) based on a study that suggests there may be additional risks of SSRI medications during pregnancy. In this study, PPHN (Persistent pulmonary hypertension of the newborn) was six times more common in babies whose mothers took an SSRI antidepressant after the 20th week of the pregnancy compared to babies whose mothers did not take an antidepressant.
Baum, Hedlund, Aristei & Goldman and Robinson Calcagnie Robinson Shapiro Davis, Inc. (RCRSD) are working together to prosecute the firms' antidepressant birth defects and PPHN cases. Both law firms are recognized preeminent plaintiff firms in the forefront of antidepressant litigation. Our attorneys have successfully handled over 3,000 SSRI-antidepressant cases in the past two decades.
Both firms have many years of experience handling pharmaceutical product liability, mass tort litigation and consumer class actions against major drug companies. They have been representing families in antidepressant birth defect cases since 2006. Anyone in need of an antidepressant birth defect lawyer should contact us for a free, no obligation consultation.